Skip to content
Review Open access

Nutri-epigenomics and its Application in the Management of Type 2 Diabetes

2026 · International journal of research and innovation in applied science · 0 citations

Abstract

Type 2 diabetes mellitus (T2DM) is a progressive metabolic disorder characterized by insulin resistance, chronic hyperglycemia, and β-cell dysfunction. Although genetic predisposition raises risk, it might not fully explain differences in the disease's onset, severity, and response to therapy. Nutriepigenomics examines how dietary exposures affect epigenetic mechanisms that regulate gene expression, including DNA methylation, histone changes, and non-coding RNAs. Because they affect insulin signaling, inflammation, oxidative stress, lipid metabolism, and glucose homeostasis, these mechanisms are crucial to the etiology and management of type 2 diabetes. The molecular foundations of nutriepigenomics and its relationship to type 2 diabetes are described in this review. A growing body of research indicates that dietary habits and bioactive substances may improve traditional antidiabetic treatment by altering glucose homeostasis-related epigenetic markers. The scientific underpinnings of nutri-epigenomics in type 2 diabetes are discussed, along with its present and future clinical uses in the prevention and treatment of the condition.

Read PDF

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.